Drug & medication recalls Moderate risk

Alvogen, Inc recalls Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah,…

Recall date
December 31, 2025
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-0259-2026
FDA classification
Class II
Brand / firm
Alvogen, Inc
Sold / distributed
US Nationwide.

Why it was recalled

Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.

Get recall alerts

Free email alert whenever Alvogen, Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Alvogen, Inc